Senores Pharmaceuticals Share Price, IPO Listing Live Updates: Senores Pharma IPO debuts Dec 30, oversubscribed 97.86x. Check ...

Compare Senores Pharma and Ventive IPOs for potential listing gains. Discover which could deliver better returns!

The stock ended at ₹562 on the NSE, down ₹38 or 6.33%, and at ₹557.80 on the BSE, down ₹35.90 or 6.05%. During the day, the ...

Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...

Ahmedabad-based Senores Pharmaceuticals raised Rs 582.11 crore through its IPO, which comprised a fresh issue of Rs 500 crore and an offer-for-sale of Rs 82.11 crore.

Shares of Senores Pharmaceuticals are scheduled to be listed on the stock exchanges today on Monday, December 30, following a ...

Senores Pharmaceuticals shares debuted with over a 50% premium on Indian exchanges, reflecting a robust investor response to ...

The Rs 582.1-crore Senores Pharmaceuticals offering consists of a fresh issue of Rs 500 crore and an offer for sale of Rs ...

Senores Pharma shares listed at Rs 593.70 apiece on the BSE, reflecting a premium of 51.84 per cent over the IPO allotment ...

As compared to the upper end of the IPO price band, Senores Pharmaceuticals' shares closed with 43.7% gains on the NSE, and ...

Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.

December 30 is set to be a busy Monday for the bourses, with shares of as many as three IPOs (initial public offerings) ...